
1. plos one. 2013 aug 15;8(8):e74511. doi: 10.1371/journal.pone.0074511. ecollection
2013.

targeted mutagenesis malaria mosquito using tale nucleases.

smidler al(1), terenzi o, soichot j, levashina ea, marois e.

author information: 
(1)institut national de la santé et de la recherche médicale u963, strasbourg,
france.

anopheles gambiae, main mosquito vector human malaria, challenging
organism manipulate genetically. consequence, reverse genetics studies in
this disease vector largely limited rna interference experiments.
here, report targeted disruption immunity gene tep1 using
transgenic expression transcription-activator like effector nucleases
(talens), isolation several tep1 mutant a. gambiae lines. these
mutations inhibited protein production rendered tep1 mutants hypersusceptible
to plasmodium berghei. talen technology opens new avenues genetic
analysis disease vector may offer novel biotechnology-based
approaches malaria control.

doi: 10.1371/journal.pone.0074511 
pmcid: pmc3744473
pmid: 23977401  [indexed medline]

